Selected research
Industry Research
In Vitro Diagnostic Devices Industry Research Report 2026
Market perspective
The global In Vitro Diagnostic Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the In Vitro Diagnostic Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the In Vitro Diagnostic Devices market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the In Vitro Diagnostic Devices market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of In Vitro Diagnostic Devices include Abbott, Thermo Fisher Scientific, Roche, Wondfo, Sysmex, Siemens Healthineers, Qiagen, Ortho Clinical Diagnostics and Myriad Genetics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global In Vitro Diagnostic Devices market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In Vitro Diagnostic Devices.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Diagnostic Devices Market by Company
Abbott
Thermo Fisher Scientific
Roche
Wondfo
Sysmex
Siemens Healthineers
Qiagen
Ortho Clinical Diagnostics
Myriad Genetics
Mindray
LG Chem
Leadman Biochemistry
KHB
Johnson and Johnson
Hologic
Danaher
DAAN Gene
BioSino
Bio-Rad Laboratories
Biomerieux
Becton Dickinson
In Vitro Diagnostic Devices Segment by Type
POCT
Molecular Diagnostics
Chemistry Diagnostics
Immuno Diagnostics
Other
In Vitro Diagnostic Devices Segment by Application
Hospitals
Laboratory
Other
In Vitro Diagnostic Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In Vitro Diagnostic Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- POCT
- Molecular Diagnostics
- Chemistry Diagnostics
- Immuno Diagnostics
- Other
Applications
- Hospitals
- Laboratory
- Other
Companies covered
- Abbott
- Thermo Fisher Scientific
- Roche
- Wondfo
- Sysmex
- Siemens Healthineers
- Qiagen
- Ortho Clinical Diagnostics
- Myriad Genetics
- Mindray
- LG Chem
- Leadman Biochemistry
- KHB
- Johnson and Johnson
- Hologic
- Danaher
- DAAN Gene
- BioSino
- Bio-Rad Laboratories
- Biomerieux
- Becton Dickinson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In Vitro Diagnostic Devices by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 POCT
- 2.2.3 Molecular Diagnostics
- 2.2.4 Chemistry Diagnostics
- 2.2.5 Immuno Diagnostics
- 2.2.6 Other
- 2.3 In Vitro Diagnostic Devices by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Laboratory
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 In Vitro Diagnostic Devices Breakdown Data by Type
- 3.1 Global In Vitro Diagnostic Devices Historic Market Size by Type (2021-2026)
- 3.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Type (2027-2032)
4 In Vitro Diagnostic Devices Breakdown Data by Application
- 4.1 Global In Vitro Diagnostic Devices Historic Market Size by Application (2021-2026)
- 4.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global In Vitro Diagnostic Devices Market Perspective (2021-2032)
- 5.2 Global In Vitro Diagnostic Devices Growth Trends by Region
- 5.2.1 Global In Vitro Diagnostic Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In Vitro Diagnostic Devices Historic Market Size by Region (2021-2026)
- 5.2.3 In Vitro Diagnostic Devices Forecasted Market Size by Region (2027-2032)
- 5.3 In Vitro Diagnostic Devices Market Dynamics
- 5.3.1 In Vitro Diagnostic Devices Industry Trends
- 5.3.2 In Vitro Diagnostic Devices Market Drivers
- 5.3.3 In Vitro Diagnostic Devices Market Challenges
- 5.3.4 In Vitro Diagnostic Devices Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In Vitro Diagnostic Devices Players by Revenue
- 6.1.1 Global Top In Vitro Diagnostic Devices Players by Revenue (2021-2026)
- 6.1.2 Global In Vitro Diagnostic Devices Revenue Market Share by Players (2021-2026)
- 6.2 Global In Vitro Diagnostic Devices Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In Vitro Diagnostic Devices Head Office and Area Served
- 6.4 Global In Vitro Diagnostic Devices Players, Product Type & Application
- 6.5 Global In Vitro Diagnostic Devices Manufacturers Established Date
- 6.6 Global In Vitro Diagnostic Devices Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In Vitro Diagnostic Devices Market Size (2021-2032)
- 7.2 North America In Vitro Diagnostic Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In Vitro Diagnostic Devices Market Size by Country (2021-2026)
- 7.4 North America In Vitro Diagnostic Devices Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In Vitro Diagnostic Devices Market Size (2021-2032)
- 8.2 Europe In Vitro Diagnostic Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In Vitro Diagnostic Devices Market Size by Country (2021-2026)
- 8.4 Europe In Vitro Diagnostic Devices Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In Vitro Diagnostic Devices Market Size (2021-2032)
- 9.2 Asia-Pacific In Vitro Diagnostic Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In Vitro Diagnostic Devices Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In Vitro Diagnostic Devices Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In Vitro Diagnostic Devices Market Size (2021-2032)
- 10.2 South America In Vitro Diagnostic Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In Vitro Diagnostic Devices Market Size by Country (2021-2026)
- 10.4 South America In Vitro Diagnostic Devices Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In Vitro Diagnostic Devices Market Size (2021-2032)
- 11.2 Middle East & Africa In Vitro Diagnostic Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In Vitro Diagnostic Devices Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In Vitro Diagnostic Devices Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.1.4 Abbott In Vitro Diagnostic Devices Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Roche
- 12.3.1 Roche Company Information
- 12.3.2 Roche Business Overview
- 12.3.3 Roche Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.3.4 Roche In Vitro Diagnostic Devices Product Portfolio
- 12.3.5 Roche Recent Developments
- 12.4 Wondfo
- 12.4.1 Wondfo Company Information
- 12.4.2 Wondfo Business Overview
- 12.4.3 Wondfo Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.4.4 Wondfo In Vitro Diagnostic Devices Product Portfolio
- 12.4.5 Wondfo Recent Developments
- 12.5 Sysmex
- 12.5.1 Sysmex Company Information
- 12.5.2 Sysmex Business Overview
- 12.5.3 Sysmex Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.5.4 Sysmex In Vitro Diagnostic Devices Product Portfolio
- 12.5.5 Sysmex Recent Developments
- 12.6 Siemens Healthineers
- 12.6.1 Siemens Healthineers Company Information
- 12.6.2 Siemens Healthineers Business Overview
- 12.6.3 Siemens Healthineers Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.6.4 Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio
- 12.6.5 Siemens Healthineers Recent Developments
- 12.7 Qiagen
- 12.7.1 Qiagen Company Information
- 12.7.2 Qiagen Business Overview
- 12.7.3 Qiagen Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.7.4 Qiagen In Vitro Diagnostic Devices Product Portfolio
- 12.7.5 Qiagen Recent Developments
- 12.8 Ortho Clinical Diagnostics
- 12.8.1 Ortho Clinical Diagnostics Company Information
- 12.8.2 Ortho Clinical Diagnostics Business Overview
- 12.8.3 Ortho Clinical Diagnostics Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio
- 12.8.5 Ortho Clinical Diagnostics Recent Developments
- 12.9 Myriad Genetics
- 12.9.1 Myriad Genetics Company Information
- 12.9.2 Myriad Genetics Business Overview
- 12.9.3 Myriad Genetics Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.9.4 Myriad Genetics In Vitro Diagnostic Devices Product Portfolio
- 12.9.5 Myriad Genetics Recent Developments
- 12.10 Mindray
- 12.10.1 Mindray Company Information
- 12.10.2 Mindray Business Overview
- 12.10.3 Mindray Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.10.4 Mindray In Vitro Diagnostic Devices Product Portfolio
- 12.10.5 Mindray Recent Developments
- 12.11 LG Chem
- 12.11.1 LG Chem Company Information
- 12.11.2 LG Chem Business Overview
- 12.11.3 LG Chem Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.11.4 LG Chem In Vitro Diagnostic Devices Product Portfolio
- 12.11.5 LG Chem Recent Developments
- 12.12 Leadman Biochemistry
- 12.12.1 Leadman Biochemistry Company Information
- 12.12.2 Leadman Biochemistry Business Overview
- 12.12.3 Leadman Biochemistry Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.12.4 Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio
- 12.12.5 Leadman Biochemistry Recent Developments
- 12.13 KHB
- 12.13.1 KHB Company Information
- 12.13.2 KHB Business Overview
- 12.13.3 KHB Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.13.4 KHB In Vitro Diagnostic Devices Product Portfolio
- 12.13.5 KHB Recent Developments
- 12.14 Johnson and Johnson
- 12.14.1 Johnson and Johnson Company Information
- 12.14.2 Johnson and Johnson Business Overview
- 12.14.3 Johnson and Johnson Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.14.4 Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio
- 12.14.5 Johnson and Johnson Recent Developments
- 12.15 Hologic
- 12.15.1 Hologic Company Information
- 12.15.2 Hologic Business Overview
- 12.15.3 Hologic Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.15.4 Hologic In Vitro Diagnostic Devices Product Portfolio
- 12.15.5 Hologic Recent Developments
- 12.16 Danaher
- 12.16.1 Danaher Company Information
- 12.16.2 Danaher Business Overview
- 12.16.3 Danaher Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.16.4 Danaher In Vitro Diagnostic Devices Product Portfolio
- 12.16.5 Danaher Recent Developments
- 12.17 DAAN Gene
- 12.17.1 DAAN Gene Company Information
- 12.17.2 DAAN Gene Business Overview
- 12.17.3 DAAN Gene Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.17.4 DAAN Gene In Vitro Diagnostic Devices Product Portfolio
- 12.17.5 DAAN Gene Recent Developments
- 12.18 BioSino
- 12.18.1 BioSino Company Information
- 12.18.2 BioSino Business Overview
- 12.18.3 BioSino Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.18.4 BioSino In Vitro Diagnostic Devices Product Portfolio
- 12.18.5 BioSino Recent Developments
- 12.19 Bio-Rad Laboratories
- 12.19.1 Bio-Rad Laboratories Company Information
- 12.19.2 Bio-Rad Laboratories Business Overview
- 12.19.3 Bio-Rad Laboratories Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.19.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio
- 12.19.5 Bio-Rad Laboratories Recent Developments
- 12.20 Biomerieux
- 12.20.1 Biomerieux Company Information
- 12.20.2 Biomerieux Business Overview
- 12.20.3 Biomerieux Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.20.4 Biomerieux In Vitro Diagnostic Devices Product Portfolio
- 12.20.5 Biomerieux Recent Developments
- 12.21 Becton Dickinson
- 12.21.1 Becton Dickinson Company Information
- 12.21.2 Becton Dickinson Business Overview
- 12.21.3 Becton Dickinson Revenue in In Vitro Diagnostic Devices Business (2021-2026)
- 12.21.4 Becton Dickinson In Vitro Diagnostic Devices Product Portfolio
- 12.21.5 Becton Dickinson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst